Astrazeneca Plc (AZN)

Operator: Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe, and good evening to those listening in Asia.

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.

Is AZN a good stock to buy? We came across a bullish thesis on AstraZeneca PLC on South Sea Investing’s Substack. In this article, we will summarize the bulls’ thesis on AZN.

AstraZeneca PLC (NYSE:AZN) is one of the best stem cell therapy stocks to buy. AstraZeneca PLC (NYSE:AZN) announced on April 21 that positive high-level results from a prespecified interim analysis of...

He stated that he is not surprised at the market resilience in the face of risk factors such as the war, oil prices, and inflation, looking at the behavior of the S&P 500 and the equity market more broadly...

The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector.

With the macroeconomic uncertainty looming over the market, the spotlight on institutional positioning gets brighter.

On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.

UK equities have spent much of the past decade trading at a discount to US peers, often overlooked in favor of faster-growing U.S. markets.